Report Detail

Other Global Personalized Cancer Vaccines Market Size, Status and Forecast 2020-2026

  • RnM4278753
  • |
  • 06 January, 2021
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Lung Cancer
    • 1.3.3 Breast Cancer
    • 1.3.4 Colorectal Cancer
    • 1.3.5 Leukemia
    • 1.3.6 Prostate Cancer
    • 1.3.7 Cervical Cancer
    • 1.3.8 Glioblastoma
    • 1.3.9 Others
  • 1.4 Market by Application
    • 1.4.1 Global Personalized Cancer Vaccines Market Share by Application: 2020 VS 2026
    • 1.4.2 Hospitals
    • 1.4.3 Homecare
    • 1.4.4 Specialty Clinics
    • 1.4.5 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Personalized Cancer Vaccines Market Perspective (2015-2026)
  • 2.2 Personalized Cancer Vaccines Growth Trends by Regions
    • 2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2015-2020)
    • 2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2021-2026)
  • 2.3 Personalized Cancer Vaccines Industry Dynamic
    • 2.3.1 Personalized Cancer Vaccines Market Trends
    • 2.3.2 Personalized Cancer Vaccines Market Drivers
    • 2.3.3 Personalized Cancer Vaccines Market Challenges
    • 2.3.4 Personalized Cancer Vaccines Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Personalized Cancer Vaccines Players by Market Size
    • 3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2015-2020)
    • 3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2015-2020)
  • 3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
  • 3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
    • 3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2019
  • 3.5 Key Players Personalized Cancer Vaccines Area Served
  • 3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
  • 3.7 Date of Enter into Personalized Cancer Vaccines Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Vaccines Breakdown Data by Type

  • 4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2015-2020)
  • 4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2021-2026)

5 Personalized Cancer Vaccines Breakdown Data by Application

  • 5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2015-2020)
  • 5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Personalized Cancer Vaccines Market Size (2015-2026)
  • 6.2 North America Personalized Cancer Vaccines Market Size by Type (2015-2020)
  • 6.3 North America Personalized Cancer Vaccines Market Size by Application (2015-2020)
  • 6.4 North America Personalized Cancer Vaccines Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Personalized Cancer Vaccines Market Size (2015-2026)
  • 7.2 Europe Personalized Cancer Vaccines Market Size by Type (2015-2020)
  • 7.3 Europe Personalized Cancer Vaccines Market Size by Application (2015-2020)
  • 7.4 Europe Personalized Cancer Vaccines Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2015-2026)
  • 8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Personalized Cancer Vaccines Market Size (2015-2026)
  • 9.2 Latin America Personalized Cancer Vaccines Market Size by Type (2015-2020)
  • 9.3 Latin America Personalized Cancer Vaccines Market Size by Application (2015-2020)
  • 9.4 Latin America Personalized Cancer Vaccines Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2015-2026)
  • 10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Advaxis Inc
    • 11.1.1 Advaxis Inc Company Details
    • 11.1.2 Advaxis Inc Business Overview
    • 11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
    • 11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2015-2020))
    • 11.1.5 Advaxis Inc Recent Development
  • 11.2 Personalis
    • 11.2.1 Personalis Company Details
    • 11.2.2 Personalis Business Overview
    • 11.2.3 Personalis Personalized Cancer Vaccines Introduction
    • 11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.2.5 Personalis Recent Development
  • 11.3 Hoffmann-La Roche Ltd
    • 11.3.1 Hoffmann-La Roche Ltd Company Details
    • 11.3.2 Hoffmann-La Roche Ltd Business Overview
    • 11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
    • 11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.3.5 Hoffmann-La Roche Ltd Recent Development
  • 11.4 BioNtech
    • 11.4.1 BioNtech Company Details
    • 11.4.2 BioNtech Business Overview
    • 11.4.3 BioNtech Personalized Cancer Vaccines Introduction
    • 11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.4.5 BioNtech Recent Development
  • 11.5 Celldex
    • 11.5.1 Celldex Company Details
    • 11.5.2 Celldex Business Overview
    • 11.5.3 Celldex Personalized Cancer Vaccines Introduction
    • 11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.5.5 Celldex Recent Development
  • 11.6 CureVac AG
    • 11.6.1 CureVac AG Company Details
    • 11.6.2 CureVac AG Business Overview
    • 11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
    • 11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.6.5 CureVac AG Recent Development
  • 11.7 Genetech
    • 11.7.1 Genetech Company Details
    • 11.7.2 Genetech Business Overview
    • 11.7.3 Genetech Personalized Cancer Vaccines Introduction
    • 11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.7.5 Genetech Recent Development
  • 11.8 Genocea
    • 11.8.1 Genocea Company Details
    • 11.8.2 Genocea Business Overview
    • 11.8.3 Genocea Personalized Cancer Vaccines Introduction
    • 11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.8.5 Genocea Recent Development
  • 11.9 Gritstone Oncology
    • 11.9.1 Gritstone Oncology Company Details
    • 11.9.2 Gritstone Oncology Business Overview
    • 11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
    • 11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.9.5 Gritstone Oncology Recent Development
  • 11.10 ISA Pharmaceuticals
    • 11.10.1 ISA Pharmaceuticals Company Details
    • 11.10.2 ISA Pharmaceuticals Business Overview
    • 11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
    • 11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 11.10.5 ISA Pharmaceuticals Recent Development
  • 11.11 Merck
    • 10.11.1 Merck Company Details
    • 10.11.2 Merck Business Overview
    • 10.11.3 Merck Personalized Cancer Vaccines Introduction
    • 10.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 10.11.5 Merck Recent Development
  • 11.12 Moderna Therapeutics
    • 10.12.1 Moderna Therapeutics Company Details
    • 10.12.2 Moderna Therapeutics Business Overview
    • 10.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
    • 10.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2015-2020)
    • 10.12.5 Moderna Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Personalized Cancer Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    By Cancer Type
    Lung Cancer
    Breast Cancer
    Colorectal Cancer
    Leukemia
    Prostate Cancer
    Cervical Cancer
    Glioblastoma
    Others
    By Mechanism of Action Type
    Tumor-associated antigens (TAAs)
    Tumor-specific antigens (TSAs)
    Somatic Mutations in Cancer Pharmacogenomics
    Pharmacogenomics towards Genomic Polymorphism

    Market segment by Application, split into
    Hospitals
    Homecare
    Specialty Clinics
    Others

    Based on regional and country-level analysis, the Personalized Cancer Vaccines market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Personalized Cancer Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Advaxis Inc
    Personalis
    Hoffmann-La Roche Ltd
    BioNtech
    Celldex
    CureVac AG
    Genetech
    Genocea
    Gritstone Oncology
    ISA Pharmaceuticals
    Merck


    Summary:
    Get latest Market Research Reports on Personalized Cancer Vaccines. Industry analysis & Market Report on Personalized Cancer Vaccines is a syndicated market report, published as Global Personalized Cancer Vaccines Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Personalized Cancer Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,841.49
    4,262.23
    5,682.98
    3,208.53
    4,812.79
    6,417.05
    404,531.40
    606,797.10
    809,062.80
    284,383.32
    426,574.98
    568,766.64
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report